Cargando…

Microvascular dysfunction in COVID-19: the MYSTIC study

RATIONALE: Pre-clinical and autopsy studies have fueled the hypothesis that a dysregulated vascular endothelium might play a central role in the pathogenesis of ARDS and multi-organ failure in COVID-19. OBJECTIVES: To comprehensively characterize and quantify microvascular alterations in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rovas, Alexandros, Osiaevi, Irina, Buscher, Konrad, Sackarnd, Jan, Tepasse, Phil-Robin, Fobker, Manfred, Kühn, Joachim, Braune, Stephan, Göbel, Ulrich, Thölking, Gerold, Gröschel, Andreas, Pavenstädt, Hermann, Vink, Hans, Kümpers, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556767/
https://www.ncbi.nlm.nih.gov/pubmed/33058027
http://dx.doi.org/10.1007/s10456-020-09753-7
_version_ 1783594281370386432
author Rovas, Alexandros
Osiaevi, Irina
Buscher, Konrad
Sackarnd, Jan
Tepasse, Phil-Robin
Fobker, Manfred
Kühn, Joachim
Braune, Stephan
Göbel, Ulrich
Thölking, Gerold
Gröschel, Andreas
Pavenstädt, Hermann
Vink, Hans
Kümpers, Philipp
author_facet Rovas, Alexandros
Osiaevi, Irina
Buscher, Konrad
Sackarnd, Jan
Tepasse, Phil-Robin
Fobker, Manfred
Kühn, Joachim
Braune, Stephan
Göbel, Ulrich
Thölking, Gerold
Gröschel, Andreas
Pavenstädt, Hermann
Vink, Hans
Kümpers, Philipp
author_sort Rovas, Alexandros
collection PubMed
description RATIONALE: Pre-clinical and autopsy studies have fueled the hypothesis that a dysregulated vascular endothelium might play a central role in the pathogenesis of ARDS and multi-organ failure in COVID-19. OBJECTIVES: To comprehensively characterize and quantify microvascular alterations in patients with COVID-19. METHODS: Hospitalized adult patients with moderate-to-severe or critical COVID-19 (n = 23) were enrolled non-consecutively in this prospective, observational, cross-sectional, multi-center study. Fifteen healthy volunteers served as controls. All participants underwent intravital microscopy by sidestream dark field imaging to quantify vascular density, red blood cell velocity (V(RBC)), and glycocalyx dimensions (perfused boundary region, PBR) in sublingual microvessels. Circulating levels of endothelial and glycocalyx-associated markers were measured by multiplex proximity extension assay and enzyme-linked immunosorbent assay. MEASUREMENTS AND MAIN RESULTS: COVID-19 patients showed an up to 90% reduction in vascular density, almost exclusively limited to small capillaries (diameter 4–6 µm), and also significant reductions of V(RBC). Especially, patients on mechanical ventilation showed severe glycocalyx damage as indicated by higher PBR values (i.e., thinner glycocalyx) and increased blood levels of shed glycocalyx constituents. Several markers of endothelial dysfunction were increased and correlated with disease severity in COVID-19. PBR (AUC 0.75, p = 0.01), ADAMTS13 (von Willebrand factor-cleaving protease; AUC 0.74, p = 0.02), and vascular endothelial growth factor A (VEGF-A; AUC 0.73, p = 0.04) showed the best discriminatory ability to predict 60-day in-hospital mortality. CONCLUSIONS: Our data clearly show severe alterations of the microcirculation and the endothelial glycocalyx in patients with COVID-19. Future therapeutic approaches should consider the importance of systemic vascular involvement in COVID-19. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10456-020-09753-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7556767
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-75567672020-10-15 Microvascular dysfunction in COVID-19: the MYSTIC study Rovas, Alexandros Osiaevi, Irina Buscher, Konrad Sackarnd, Jan Tepasse, Phil-Robin Fobker, Manfred Kühn, Joachim Braune, Stephan Göbel, Ulrich Thölking, Gerold Gröschel, Andreas Pavenstädt, Hermann Vink, Hans Kümpers, Philipp Angiogenesis Original Paper RATIONALE: Pre-clinical and autopsy studies have fueled the hypothesis that a dysregulated vascular endothelium might play a central role in the pathogenesis of ARDS and multi-organ failure in COVID-19. OBJECTIVES: To comprehensively characterize and quantify microvascular alterations in patients with COVID-19. METHODS: Hospitalized adult patients with moderate-to-severe or critical COVID-19 (n = 23) were enrolled non-consecutively in this prospective, observational, cross-sectional, multi-center study. Fifteen healthy volunteers served as controls. All participants underwent intravital microscopy by sidestream dark field imaging to quantify vascular density, red blood cell velocity (V(RBC)), and glycocalyx dimensions (perfused boundary region, PBR) in sublingual microvessels. Circulating levels of endothelial and glycocalyx-associated markers were measured by multiplex proximity extension assay and enzyme-linked immunosorbent assay. MEASUREMENTS AND MAIN RESULTS: COVID-19 patients showed an up to 90% reduction in vascular density, almost exclusively limited to small capillaries (diameter 4–6 µm), and also significant reductions of V(RBC). Especially, patients on mechanical ventilation showed severe glycocalyx damage as indicated by higher PBR values (i.e., thinner glycocalyx) and increased blood levels of shed glycocalyx constituents. Several markers of endothelial dysfunction were increased and correlated with disease severity in COVID-19. PBR (AUC 0.75, p = 0.01), ADAMTS13 (von Willebrand factor-cleaving protease; AUC 0.74, p = 0.02), and vascular endothelial growth factor A (VEGF-A; AUC 0.73, p = 0.04) showed the best discriminatory ability to predict 60-day in-hospital mortality. CONCLUSIONS: Our data clearly show severe alterations of the microcirculation and the endothelial glycocalyx in patients with COVID-19. Future therapeutic approaches should consider the importance of systemic vascular involvement in COVID-19. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10456-020-09753-7) contains supplementary material, which is available to authorized users. Springer Netherlands 2020-10-14 2021 /pmc/articles/PMC7556767/ /pubmed/33058027 http://dx.doi.org/10.1007/s10456-020-09753-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Paper
Rovas, Alexandros
Osiaevi, Irina
Buscher, Konrad
Sackarnd, Jan
Tepasse, Phil-Robin
Fobker, Manfred
Kühn, Joachim
Braune, Stephan
Göbel, Ulrich
Thölking, Gerold
Gröschel, Andreas
Pavenstädt, Hermann
Vink, Hans
Kümpers, Philipp
Microvascular dysfunction in COVID-19: the MYSTIC study
title Microvascular dysfunction in COVID-19: the MYSTIC study
title_full Microvascular dysfunction in COVID-19: the MYSTIC study
title_fullStr Microvascular dysfunction in COVID-19: the MYSTIC study
title_full_unstemmed Microvascular dysfunction in COVID-19: the MYSTIC study
title_short Microvascular dysfunction in COVID-19: the MYSTIC study
title_sort microvascular dysfunction in covid-19: the mystic study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556767/
https://www.ncbi.nlm.nih.gov/pubmed/33058027
http://dx.doi.org/10.1007/s10456-020-09753-7
work_keys_str_mv AT rovasalexandros microvasculardysfunctionincovid19themysticstudy
AT osiaeviirina microvasculardysfunctionincovid19themysticstudy
AT buscherkonrad microvasculardysfunctionincovid19themysticstudy
AT sackarndjan microvasculardysfunctionincovid19themysticstudy
AT tepassephilrobin microvasculardysfunctionincovid19themysticstudy
AT fobkermanfred microvasculardysfunctionincovid19themysticstudy
AT kuhnjoachim microvasculardysfunctionincovid19themysticstudy
AT braunestephan microvasculardysfunctionincovid19themysticstudy
AT gobelulrich microvasculardysfunctionincovid19themysticstudy
AT tholkinggerold microvasculardysfunctionincovid19themysticstudy
AT groschelandreas microvasculardysfunctionincovid19themysticstudy
AT pavenstadthermann microvasculardysfunctionincovid19themysticstudy
AT vinkhans microvasculardysfunctionincovid19themysticstudy
AT kumpersphilipp microvasculardysfunctionincovid19themysticstudy